Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...
New York, Nov. 06, 2019 (GLOBE NEWSWIRE) -- Growth in demand for anemia screening, demand from blood banks for disease screening, competitive prices, along with growing need for disease diagnosis and ...